Moldovianu, A.-M.; Stoia, R.; Vasilica, M.; Ursuleac, I.; Badelita, S.N.; Tomescu, A.A.; Preda, O.D.; Bardas, A.; Cirstea, M.; Coriu, D.
Real-World Clinical Outcomes and Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Single-Center Retrospective Study. Medicina 2023, 59, 324.
https://doi.org/10.3390/medicina59020324
AMA Style
Moldovianu A-M, Stoia R, Vasilica M, Ursuleac I, Badelita SN, Tomescu AA, Preda OD, Bardas A, Cirstea M, Coriu D.
Real-World Clinical Outcomes and Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Single-Center Retrospective Study. Medicina. 2023; 59(2):324.
https://doi.org/10.3390/medicina59020324
Chicago/Turabian Style
Moldovianu, Ana-Maria, Razvan Stoia, Mariana Vasilica, Iulia Ursuleac, Sorina Nicoleta Badelita, Andra Alina Tomescu, Oana Diana Preda, Alexandru Bardas, Mihaela Cirstea, and Daniel Coriu.
2023. "Real-World Clinical Outcomes and Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Single-Center Retrospective Study" Medicina 59, no. 2: 324.
https://doi.org/10.3390/medicina59020324
APA Style
Moldovianu, A.-M., Stoia, R., Vasilica, M., Ursuleac, I., Badelita, S. N., Tomescu, A. A., Preda, O. D., Bardas, A., Cirstea, M., & Coriu, D.
(2023). Real-World Clinical Outcomes and Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Single-Center Retrospective Study. Medicina, 59(2), 324.
https://doi.org/10.3390/medicina59020324
